Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Medical Tech Outlook
THANK YOU FOR SUBSCRIBING
Mediflex Inc. has been recognized by MedTech Outlook Magazine as the exclusive recipient of “Top 10 Endoscopy Solutions Companies - 2022 ,” based on our proprietary methodology, reflecting its position in the industry. This profile has been developed by the MedTech Outlook research and editorial team based on insights from an interview with David Weiss, CEO.

With every specification, its proprietary coating remains more resilient than the original and reprocessed tube’s constructed from polyolefin heat shrink tubing. The coating is deemed strong as it can withstand exposure to 600 cycles of hydrogen peroxide and sterilizers to exceed the performance of other manufacturer’s base coating.![]()
The insertion tubes are manufactured in alignment with as many as seven different durometer during the production process to address each manufacturer’s specification
Company
Mediflex Inc.
Management
David Weiss, CEO
Description
Mediflex Inc is an FDA compliant, ISO company that manufactures insertion tubes of original equipment manufacturers to be used as replacements. The tubes are coated with their proprietary, ISO 10-993 compliant coating with fewer layers than traditional insertion tubes, making it available at a lesser cost than other disposable insertion tubes.
Sito Web:
mythras.it
Amministratore:
Roberto Livio Mastronardi, co-fondatore
Descrizione:
Mythras è un team di tecnici specializzati nell'assistenza tecnica su strumentazione IVD, esperti nell'aiutare i responsabili di laboratorio a garantire la precisione, l'accuratezza e la conformità dei loro strumenti. È la scelta ideale per numerosi clienti e distributori, al servizio delle loro complesse esigenze di assistenza tecnica e ricondizionamento della strumentazione IVD.
Citazione:
“Siamo certificati ISO 9001:2015 per l'assistenza tecnica e il ricondizionamento della strumentazione analitica IVD.”
I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info
